RegentAtlantic Capital’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | $4.3M | Buy |
14,836
+7,964
| +116% | +$2.31M | 0.13% | 117 |
|
|
2022
Q2 | $1.94M | Buy |
6,872
+724
| +12% | +$204K | 0.06% | 215 |
|
|
2022
Q1 | $1.6M | Buy |
6,148
+1,078
| +21% | +$281K | 0.05% | 249 |
|
|
2021
Q4 | $1.11M | Buy |
5,070
+1,096
| +28% | +$241K | 0.03% | 309 |
|
|
2021
Q3 | $721K | Buy |
3,974
+136
| +4% | +$24.7K | 0.02% | 361 |
|
|
2021
Q2 | $774K | Buy |
3,838
+138
| +4% | +$27.8K | 0.02% | 333 |
|
|
2021
Q1 | $795K | Buy |
3,700
+1,371
| +59% | +$295K | 0.03% | 309 |
|
|
2020
Q4 | $550K | Sell |
2,329
-33
| -1% | -$7.79K | 0.02% | 325 |
|
|
2020
Q3 | $643K | Buy |
2,362
+1,040
| +79% | +$283K | 0.03% | 289 |
|
|
2020
Q2 | $384K | Buy |
+1,322
| New | +$384K | 0.02% | 340 |
|
|
2015
Q1 | – | Sell |
-115
| Closed | -$13.7K | – | 942 |
|
|
2014
Q4 | $13.7K | Buy |
+115
| New | +$13.7K | ﹤0.01% | 839 |
|